Financials
Value Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 93.55 K423.61 K93.54 K145.13 K125 K 787.28 K Research & development ————— — Operating income -93.55 K-423.61 K-93.54 K-145.13 K-125 K -787.28 K Non-Operating Income, Total 87.76 K575.53 K536.97 K494.17 K282.26 K 1.89 M Interest expense, net of interest capitalized 100 K100 K100 K100 K100 K 400 K Non-Operating Income, excl. Interest Expenses -12.24 K475.53 K436.97 K394.17 K182.26 K 1.49 M Unusual income/expense ————— — Pretax income -5 791240.36 K455.95 K359.47 K166.8 K 1.22 M Equity in earnings ————— — Taxes 00000 — Non-controlling/minority interest ————— — After tax other income/expense ————— — Net income before discontinued operations -5 791240.36 K455.95 K359.47 K166.8 K 1.22 M Discontinued operations ————— — Net income -5 791240.36 K455.95 K359.47 K166.8 K 1.22 M Dilution adjustment -87.76 K-575.53 K-536.97 K-494.17 K-282.26 K -1.89 M Preferred dividends -87.76 K-575.53 K-536.97 K-494.17 K-282.26 K -1.89 M Diluted net income available to common stockholders -5 791240.36 K455.95 K359.47 K166.8 K 1.22 M Basic earnings per share (Basic EPS) -0.09-0.130.270.37-0.14 0.37 Diluted earnings per share (Diluted EPS) -0.09-0.130.270.37-0.14 0.37 Average basic shares outstanding 1.42 M1.74 M1.78 M1.9 M1.9 M — Diluted shares outstanding 1.42 M1.74 M1.78 M1.9 M1.9 M — EBITDA ————— — EBIT ———1.23 B-1.14 B — Cost of revenue ————— — Other cost of goods sold ————— — Depreciation & amortization (cash flow) ————— —